Entelos news from FierceBiotech
NewsEntelos inks deal with Lilly
Shares of the UK's Entelos surged after the company reported a licensing pact with Eli Lilly. The pact covers access to Entelos' database of 630 drug profiles, which is used to test an experimental Read more...
ALSO NOTED: MonoSol Rx sets IPO; Entelos buys Iconix; and much more...
> MonoSol Rx has set the terms on an IPO of four million shares. The offering is expected to raise up to $70 million if its hits its range of $16 to $18 a share. Read more...
ALSO NOTED: Integra buys IsoTis for $49.3M; MannKind searches for insulin drug partner; and much more...
> Device maker Integra LifeSciences is buying IsoTis for $49.3 million. Read more...
| Press ReleasesPRESS RELEASE: Entelos Acquires Iconix Biosciences Entelos Acquires Iconix Biosciences Foster City, CA, August 30, 2007 – Entelos, a leading life sciences company that leverages its proprietary in silico disease models, known as PhysioLab® Read more... PRESS RELEASE: Entelos to Design Computer Model for Prediction of Drug-Induced Human Liver InjuryEntelos to Design Computer Model for Prediction of Drug-Induced Human Liver Injury GEN News Highlights Aug. 6 -- Entelos entered into a two-year CRADA with FDA’s Center for Drug Evaluation and Read more... |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets